SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Amgen Inc. (AMGN)
An SI Board Since December 1996
Posts SubjectMarks Bans Symbol
1906 112 0 AMGN
Emcee:  trevor john wilkinson Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
1781CS: Biotechnology MARKET WEIGHT M. Aberman AMGN, JNJ - Another Negative ESA Headmopgcw-1/7/2010
1780Mircera legal action settled: >>THOUSAND OAKS, Calif., Dec. 22 /PRNewswirtuck-12/22/2009
1779CS: Amgen Inc. (AMGN) OUTPERFORM M. Aberman CP: US$ 54.58 TP: US$ 70 CAP: US$ 55mopgcw-12/19/2009
1778IP setback for Amgen regarding Hypoxia Inducible Factor. >>FibroGen, Intuck-12/7/2009
1777CS: Amgen Inc. (AMGN) OUTPERFORM M. Aberman CP: US$ 53.62 TP: US$ 70 CAP: US$ 54mopgcw-11/2/2009
1776thanks for the pointer.mopgcw-10/23/2009
1775Citi: Amgen Inc (AMGN) FDA HALTing Prolia; Are There Concerning Crossreads to SRmopgcw-10/23/2009
1774<i>>The company has also been asked to conduct additional studies for tDewDiligence_on_SI-10/23/2009
1773zacks: Amgen Q3: Beats Nicely, Raises Guidance Amgen (AMGN) reported third quamopgcw-10/23/2009
1772CS: Amgen Inc. (AMGN) OUTPERFORM M. Aberman CP: US$ 59.40 TP: US$ 75 CAP: US$ 60mopgcw-10/22/2009
1771Seeking Alpha: CC Amgen, Inc. (AMGN) Q3 2009 Earnings Call October 21, 2009 5:mopgcw-10/22/2009
1770That sounds reasonable. Surely the answer could be mined? But what I enjoyed watom pope-10/21/2009
1769<i>The Company also announced that it has received a Complete Response Letkeokalani'nui-10/21/2009
1768Desperately Seeking Denosumab: siliconinvestor.comDewDiligence_on_SI-10/21/2009
1767NEW YORK, Oct 19 (Reuters) - U.S. health regulators have delayed approval of Amgtom pope-10/19/2009
1766Amgen Upped to Buy at UBS $61 billion (market cap) drug giant Amgen (AMGN) is umopgcw-10/13/2009
1765Barrons: Biotechs That Could Rebound Morgan Joseph likes Onyx Pharma, Isis Pharmmopgcw-10/4/2009
1764Citi: Amgen Inc (AMGN) 9/24/09 LIVE From ESMO 2009: Vectibix Shows Early OS Tremopgcw-9/26/2009
1763Too busy harvesting grapes to remember or look back at that; thanks for the catctuck-9/25/2009
1762Lack of superiority to Zometa has been known since the top-line results were annDewDiligence_on_SI-9/23/2009
1761Not sure, but the market may have been looking for statistical superiority to Zotuck-9/23/2009
1760Beats the heck out of me! I had placed a S/L @$62.00 to protect my nice gain, jArthur Radley-9/22/2009
1759what didn't the market like?bob zagorin-9/22/2009
1758Outstanding result in PR announcement this morning......especially the SRE part.Arthur Radley-9/22/2009
1757Amgen announced detailed results from a Phase 3 trial evaluating denosumab adminbob zagorin19/21/2009
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News